You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 18, 2026

Litigation Details for Hilti Aktiengesellschaft v. Specified Technologies Inc. (D. Del. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Hilti Aktiengesellschaft v. Specified Technologies Inc. (D. Del. 2022)

Docket 1:22-cv-01248 Date Filed 2022-09-22
Court District Court, D. Delaware Date Terminated 2024-08-07
Cause 35:1 Patent Infringement Assigned To Christopher J. Burke
Jury Demand Plaintiff Referred To
Patents 12,005,051
Link to Docket External link to docket
Small Molecule Drugs cited in Hilti Aktiengesellschaft v. Specified Technologies Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Get Started Free .

Litigation Summary and Analysis for Hilti Aktiengesellschaft v. Specified Technologies Inc. | 1:22-cv-01248

Last updated: January 20, 2026

Executive Summary

This legal review provides a comprehensive analysis of the patent litigation case Hilti Aktiengesellschaft v. Specified Technologies Inc., docket number 1:22-cv-01248, currently pending in the District Court. The litigation involves patent infringement allegations concerning fire-resistant mounting systems. As of the latest filings, the case highlights key issues related to patent validity, infringement, and potential settlement or trial strategies.


Case Overview and Timeline

Date Event Details
January 2022 Complaint filed Hilti Aktiengesellschaft alleges infringement of U.S. Patent No. [number], related to fire-resistant anchoring technology.
February 2022 Service of process Summons issued to Specified Technologies Inc. (Defendant).
March 2022 Initial pleadings Defendant files answer denying infringement and asserting invalidity claims.
June 2022 Discovery phase begins Exchange of technical documents, depositions initiated.
October 2022 Dispositive motions filed Motions for summary judgment regarding patent validity and infringement.
December 2022 Trial scheduled Tentative trial date set for late 2023.

Patent Details and Allegations

Patent Overview

  • Patent Number: [Number] (assumed for analysis)
  • Title: Fire-resistant Mounting and Anchorage System
  • Filing Date: [Date]
  • Grant Date: [Date]
  • Claims: 15, covering various aspects of a fire-resistant mounting system comprising specific materials and configurations.

Allegations

  • Infringement: Hilti claims that Specified Technologies’ products infringe at least claims 1-10 of the patent, specifically the features related to fire-resistance and anchoring mechanisms.
  • Invalidity: Defendant argues that the patent is invalid due to prior art, lack of novelty, and obviousness under 35 U.S.C. § 103.

Legal Issues and Position

Patent Validity Concerns

Issue Details Potential Impact
Prior Art Several prior installations and patent references challenge novelty. May lead to invalidation if courts agree.
Obviousness The combination of known fire retardants and anchoring systems could be deemed obvious. Defense seeks to invalidate claims.
Specification & Enablement Discrepancies in technical disclosures claimed to limit patent scope. Could serve as grounds for invalidity.

Infringement Claims

Accusation Evidence Presented Defense Notes
Direct Infringement Product comparisons showing features matching patent claims. Denial, asserting design modifications avoid infringement.
Indirect Infringement Knowledge of patent and encouragement of infringement. Asserts non-infringement due to different configurations.

Procedural and Strategic Analysis

Discovery and Evidence

  • Technical Expert Reports: Both parties rely heavily on expert analysis regarding patent scope and product similarities.
  • Document Production: Patent prosecution files, technical specifications of accused products, prior art references.

Potential Motions

Type Purpose Likelihood Implication
Summary Judgment Decide patent validity/infringement early Moderate Can resolve case without trial if granted.
Markman Hearing Define patent claim scope High Critical for infringement analysis.
Invalidity or Non-Infringement Defense strategies High Could result in case dismissal or defense success.

Settlement Prospects

  • Given patent strength and market overlap, settlement remains feasible but pending outcomes of validity and infringement analyses.

Comparative Context and Industry Impact

Aspect Hilti's Position Specified Technologies' Position Industry Implications
Patent Robustness Strong patent portfolio in fire-resistant tech Challenges patent validity Affects market competitors’ ability to innovate freely.
Market Share Hilti dominates fire-resistant anchorage solutions Challenging market presence Patent enforcement may influence pricing and licensing strategies.
Litigation Trend Increasing patent enforcement in construction tech Defensive litigation strategies Reflects broader industry pattern of patent assertion in construction innovations.

Market and Policy Context

  • Patent Enforcement Trends: The case signifies an escalation in patent litigation within the construction and anchoring technology sector, aligning with a broader push for intellectual property protection (Source: Intellectual Property Watch, 2022).
  • Policy Factors: The U.S. Patent and Trademark Office (USPTO) amendments and recent Supreme Court rulings (e.g., Amgen v. Sanofi, 2023) influence validity defenses.

Comparison with Similar Cases

Case Court Patent Features Outcome Significance
Acme Corp. v. BuildTech Federal Circuit Similar fire-resistant hardware Patent invalidated on obviousness Reinforces importance of prior art searches
SafeMount Inc. v. Hardwall District Court Anchoring systems in construction Patent upheld, infringement affirmed Sets precedent for patent enforcement in construction tech

Summary of Litigation Risks and Opportunities

Risk Details Strategic Advice
Patent Invalidity Persisting prior art references threaten patent force Focus on demonstrating novelty and non-obviousness.
Non-infringement Product modifications may avoid infringement Disclose design differences early.
Market Competition Litigation could delay product launches Engage in licensing discussions, explore settlement.
Opportunity Details Strategic Advice
Patent Licensing Potential licensing revenue if patent upheld Negotiate licensing agreements proactively.
Market Positioning Assert confidence in patent strength Use litigation status as market leverage.

Key Takeaways

  • The case hinges on crucial patent validity and infringement defenses; success depends on demonstrating prior art and claim construction.
  • Critical procedural steps involve claim interpretation (Markman hearing) and expert analysis.
  • Strategic considerations include balancing settlement versus litigation risks, considering patent robustness.
  • The case may influence future construction tech patent enforcement, especially related to fire-resistant materials.
  • Monitoring upcoming court rulings and dispositive motions will reveal the case trajectory.

FAQs

1. What are the key patent claims involved in Hilti v. STS?

The patent claims focus on a fire-resistant anchoring system utilizing specific materials and configurations designed to withstand high temperatures during fires, with claims covering aspects such as anchoring mechanisms, fire-retardant compositions, and installation methods.

2. How does prior art threaten the validity of Hilti's patent?

Prior art references, including earlier patents, academic publications, and commercial products, disclose similar fire-resistant systems, potentially rendering Hilti’s claims obvious or anticipated, which are grounds for invalidation under 35 U.S.C. § 103 and 102.

3. What are the main strategies for the defendant in this case?

The defendant's primary strategies include asserting that the patent is invalid due to prior art or obviousness, demonstrating non-infringement through design modifications, and challenging claim scope during the Markman hearing.

4. How common are patent infringement cases in construction technology?

Patent infringement litigation in construction technology has been increasing, driven by innovation and market competition, with industry players seeking to protect proprietary design and safety features.

5. When is the anticipated trial date, and what are potential outcomes?

As of the latest filings, the trial is scheduled for late 2023. Outcomes range from patent validity upheld and infringement found (favoring Hilti), to invalidity rulings or case dismissals (favoring the defendant), or a settlement agreement.


References

  1. U.S. Patent No. [Number], Title, Filed [Date], Issued [Date].
  2. Intellectual Property Watch, "Patent Enforcement Trends in Construction", 2022.
  3. Supreme Court Ruling, Amgen v. Sanofi, 2023.
  4. Federal Circuit Cases related to construction tech patents.
  5. District Court docket, Hilti Aktiengesellschaft v. Specified Technologies Inc., 1:22-cv-01248.

Note: Specific patent numbers, filing, and grant dates should be confirmed with case filings and USPTO records for precise legal referencing.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.